Pays: Royaume-Uni
Langue: anglais
Source: MHRA (Medicines & Healthcare Products Regulatory Agency)
Guaifenesin
Haleon UK Ltd
R05CA03
Guaifenesin
10mg/1ml
Oral solution
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 03090200; GTIN: 5051562013101
OBJECT 1 TIXYLIX CHESTY COUGH Summary of Product Characteristics Updated 05-Aug-2013 | GlaxoSmithKline Consumer Healthcare 1. Name of the medicinal product Tixylix ® Chesty Cough 2. Qualitative and quantitative composition Each 5ml contains Guaifenesin 50mg For excipients see section 6.1 3. Pharmaceutical form Linctus A clear, colourless or straw coloured solution 4. Clinical particulars 4.1 Therapeutic indications Expectorant for the symptomatic relief of acute productive (chesty) cough. The linctus is for the lubrication and relief of the sore throat and hoarseness, which may be associated with the cough. 4.2 Posology and method of administration The following dose is taken 4 hourly. Do not exceed 6 doses in 24 hours. Tixylix Chesty Cough is contra-indicated in children under 6 years of age. 6 10 years 5 to 10ml Not to be used for more than 5 days without the advice of a doctor. Parents or carers should seek medical advice if the child's condition deteriorates during treatment. Do not exceed the stated dose. Keep out of the sight and reach of children. 4.3 Contraindications Hypersensitivity to the active ingredients or to any of the excipients. Not to be used in children under 6 years of age. 4.4 Special warnings and precautions for use Consult a doctor before use if suffering from an acute asthma attack, a chronic cough or are asthmatic. Stop use and consult a healthcare professional if the cough persists for longer than 5 days. Stop use and consult a healthcare professional if the cough is accompanied by a fever, rash or persistent headache or is recurrent. If symptoms persist, consult a doctor. Keep out of the sight and reach of children. Do not exceed the stated dose. Do not take with any other cough and cold medicine, including cough suppressants. 4.5 Interaction with other medicinal products and other forms of interaction Should not be taken with a cough suppressant. If urine is collected within 24 hours of a dose of Tixylix Chesty Cough a metabolite of guaifenesin may cause a colour interference with Lire le document complet